Ekso Bionics Reports First Quarter 2017 Results
May 09, 2017 20:10 pm UTC| Business
RICHMOND, Calif., May 09, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today reported financial results for the three months ended March 31, 2017. Recent Highlights and...
Ekso Bionics Reports First Quarter 2017 Results
May 09, 2017 20:10 pm UTC| Business
RICHMOND, Calif., May 09, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today reported financial results for the three months ended March 31, 2017. Recent Highlights and...
Ekso Bionics Reports First Quarter 2017 Results
May 09, 2017 20:10 pm UTC| Business
RICHMOND, Calif., May 09, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today reported financial results for the three months ended March 31, 2017. Recent Highlights and...
May 09, 2017 20:10 pm UTC| Business
MALVERN, Pa., May 09, 2017 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biotechnology company, today announced that the U.S. Food and Drug Administration has accepted its New Drug Application (NDA)...
May 09, 2017 20:10 pm UTC| Business
MALVERN, Pa., May 09, 2017 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biotechnology company, today announced that the U.S. Food and Drug Administration has accepted its New Drug Application (NDA)...
Codexis Reports Financial Results for the First Quarter of 2017
May 09, 2017 20:10 pm UTC| Business
Product sales increase 49% Highlights include signing second multiyear agreement in the food industry and initiating beta testing of first company-developed enzyme for the molecular diagnostics industry Conference...
May 09, 2017 20:10 pm UTC| Business
MALVERN, Pa., May 09, 2017 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biotechnology company, today announced that the U.S. Food and Drug Administration has accepted its New Drug Application (NDA)...